Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00304525
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2006-03-17
Brief Title:
A Study to Evaluate RAF265 an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-17
First Submit QC Date:
March 17 2006
Study First Post Date:
2006-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-08-20
Disp First Submit QC Date:
August 28 2020
Disp First Post Date:
2020-09-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL